When identified at an early stage, patient has 95% chance of cure
According to the National Cancer Institute (Inca), breast cancer is the most common type among women in Brazil and worldwide, there are more than 59 thousand cases per year. In Curitiba, the entity estimates 570 new cases this year. According to Myrna Campagnoli, medical director of the Frischmann Aisengart Laboratory – which is part of Dasa, women cannot fail to carry out breast cancer prevention tests, even in the pandemic, mainly to monitor and because in the initial stage the patient has 95% of chances of cure. “The earlier the tumor is detected, the greater the probability of cure and, depending on the location of the nodule, the less aggressive the treatment will be”, he explains. “It is important to reinforce that the test cannot wait, and even in the pandemic, patients with a family history and women over 40 must undergo preventive tests annually.”, He adds.
The main exam for breast cancer detection is mammography. According to a survey by the São Camilo laboratory, this year the units will account for a 40% decrease in mammograms compared to last year. “Mammography is one of the main exams to monitor breast health, as it can identify nodules that are not yet palpable. Patients with a family history, on the other hand, should start the evaluation first ”, he explains.
Breast cancer is usually caused by the mutation of a healthy cell, but it can also be hereditary, passing from mother to daughter. “About 10% of breast cancer cases are hereditary, so when there are cases in the family, there is a chance of presenting the mutation, so it is important to investigate,” he says. The main genetic tests that detect the predisposition for breast cancer are the sequencing and MLPA of BRCA1 and BRCA2. “BRCA 1 and 2 are repair genes, tumor suppressors and in the sequencing we evaluated whether they have any mutations. If the changes are detected, it means that the person is ready to develop the disease ”, he explains. To complement these tests, the hereditary cancer panel can also be performed, which will analyze other genes, in addition to the two mentioned.
When the test shows a high probability for breast cancer, several measures can be taken to decrease the risk of developing the disease or to make the diagnosis as early as possible. The patient will undergo continuous monitoring with the mastologist, which can be every six months, respecting the peculiarities of each case. The doctor may also order preventive exams or, in some cases, perform risk-reducing surgery, such as mastectomy.
“We are living in very difficult times, despite the relaxation of social isolation measures, the population still remains with low levels of immunity and viruses are still circulating. That is why we cannot neglect ourselves, maintaining hygiene measures and avoiding unnecessary crowds. With all necessary precaution, we must maintain routine consultations and tests to monitor our health because other diseases such as breast cancer have not ceased to exist. Health care requires people to keep medical appointments and exams up to date ”, concludes Myrna.
About FRISCHMANN AISENGART
For 75 years Frischmann Aisengart has been offering the most modern in diagnostic medicine, working with clinical analysis tests, hormonal tests, genetic tests, among others, in addition to the application of vaccines. With more than 40 units in Paraná, it offers differentials to its patients such as the Home Collection service, online scheduling, pediatrics with the Scooby-Doo class, among others. The Frischmann Aisengart laboratory is part of Dasa, the Brazilian leader in diagnostic medicine and the largest company in the sector in Latin America, a network that processes 250 million exams per year, serving more than 20 million people across the country, with a portfolio of over 2,500 different types of exams.